NCT04698200

Brief Summary

Both high and low environmental temperatures are associated worldwide with higher morbidity and mortality and an estimated 8% of the mortality is estimated to relate to non-optimum temperatures. The majority of the adverse health effects occur at to low, and not high temperatures, and already with a modest change in temperature. Persons with type 2 diabetes can be sensitive to the effect of temperature due to their altered neural, metabolic and circulatory functions. The pathophysiological responses of type 2 diabetes in a cold and hot environment are not known. The aim of the study is to examine how advanced type 2 diabetes (disease progression \>10 years) alone, an in conjunction with coronary artery diseases and hypertension affect neural, cardiovascular and metabolic responses in a cold and hot environment. Type 2 diabetes is associated with altered neural regulation, weakened cardiovascular function, structural changes in blood vessels, altered blood constitution and metabolic disturbances. These affect thermoregulation and result in increased susceptibility to cold (lesser heat production, increased heat loss) and heat (lesser sweating and heat loss). The patients are exposed under controlled conditions in a random order to both cold (+10°C) and heat (+44°C) while resting and lightly clothed for 90 min at a time. The exposure itself is preceded by baseline measurements of the parameters of interest, and followed by repeating the same measurements after the exposure. The topic of the research is very relevant due to the worldwide epidemic of type 2 diabetes. Simultaneously, the comorbid conditions associated with diabetes become more common and are related to a higher occurrence of cardiac events. The research information is useful for all individuals with type 2 diabetes in their protection and self-management of the disease, and enabling to maintain functional ability in a cold or hot environment. The research knowledge can be utilized when developing weather warning systems for the identification of susceptible populations. Health care personnel may utilize the research information while advising their patients and for proper care. An increased awareness of the health effects of both low and high temperatures improve the functional ability of individuals and reduced help reducing morbidity and mortality from weather conditions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable type-2-diabetes

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 6, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

June 18, 2021

Status Verified

June 1, 2021

Enrollment Period

2.9 years

First QC Date

November 23, 2020

Last Update Submit

June 17, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of systolic and diastolic blood pressure

    Brachial, central and beat-to-beat systolic and diastolic blood pressure

    10, 20 and 30 minutes before the intervention, during the intervention in 10 minutes intervals, and 5, 10, 15, 20 25 and 30 minutes after the intervention.

Secondary Outcomes (4)

  • Electrocardiogram, ECG

    3 hours

  • Metabolic rate

    During the 60 minutes intervention period.

  • Sweating

    During the 60 minutes intervention period and immediately after the intervention.

  • Skin and body temperature

    3 hours

Study Arms (1)

Blood pressure

EXPERIMENTAL

Measurement of brachial, central and beat-to-beat blood pressure.

Other: Cold exposure

Interventions

Whole body resting cold (+10 degrees centigrade) and heat (+40 degrees centigrade) for 60 minutes.

Also known as: Heat exposure
Blood pressure

Eligibility Criteria

Age40 Years - 70 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-smoking
  • Type 2 diabetes
  • Hypertension

You may not qualify if:

  • Smoking
  • Chronic respiratory diseases
  • Coronary artery diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oulu, Center for Environmental and Respiratory Health Research

Oulu, FI-90014, Finland

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2020

First Posted

January 6, 2021

Study Start

January 1, 2021

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

June 18, 2021

Record last verified: 2021-06

Locations